Literature DB >> 2557615

Nerve growth factor induces growth and differentiation of human B lymphocytes.

U Otten1, P Ehrhard, R Peck.   

Abstract

Nerve growth factor (NGF) is known to affect peripheral sympathetic and sensory neurons as well as defined populations of neurons in the central nervous system. This paper presents evidence that NGF is also active in modulation of B-cell-mediated immune responses. NGF receptors were immunoprecipitated from highly purified human B-cell populations, and to a lesser extent, from T-cell populations, by using a monoclonal antibody recognizing NGF receptors present on neural cells. NGF receptors were also detected in significant amounts in human spleen and lymph node tissue. In addition, NGF induced a dose-dependent increase in B-cell DNA synthesis as determined by incorporation of [3H]thymidine. This B-cell growth-promoting activity was inhibited by a neutralizing anti-NGF monoclonal antibody. Immunoglobulin secretion, principally affecting IgM synthesis, was also modulated by NGF. The concentrations that affected B-cell proliferation are consistent with the presence of functional high-affinity NGF receptors. The results suggest that NGF, in addition to its neurotrophic function, also acts as an immunoregulatory cytokine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557615      PMCID: PMC298643          DOI: 10.1073/pnas.86.24.10059

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Binding characteristics and apparent molecular size of detergent solubilized nerve growth factor receptor of sympathetic ganglia.

Authors:  N V Costrini; R A Bradshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Mast cells increase in tissues of neonatal rats injected with the nerve growth factor.

Authors:  L Aloe; R Levi-Montalcini
Journal:  Brain Res       Date:  1977-09-16       Impact factor: 3.252

Review 3.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

Review 4.  Physiology of nerve growth factor.

Authors:  H Thoenen; Y A Barde
Journal:  Physiol Rev       Date:  1980-10       Impact factor: 37.312

5.  Nerve growth factor receptors on PC12 cells: evidence for two receptor classes with differing cytoskeletal association.

Authors:  A L Schechter; M A Bothwell
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

6.  The nerve growth factor: purification as a 30,000-molecular-weight protein.

Authors:  V Bocchini; P U Angeletti
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

7.  Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor.

Authors:  E M Johnson; P D Gorin; L D Brandeis; J Pearson
Journal:  Science       Date:  1980-11-21       Impact factor: 47.728

8.  Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells.

Authors:  A Sutter; R J Riopelle; R M Harris-Warrick; E M Shooter
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

9.  Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits.

Authors:  F Gudat; A Laubscher; U Otten; A Pletscher
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

10.  A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas.

Authors:  I Stamenkovic; E A Clark; B Seed
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  62 in total

Review 1.  Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis.

Authors:  E M Frohman; N L Monson; A E Lovett-Racke; M K Racke
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

Review 2.  Neurotrophins and the immune system.

Authors:  José A Vega; Olivia García-Suárez; Jonas Hannestad; Marta Pérez-Pérez; Antonino Germanà
Journal:  J Anat       Date:  2003-07       Impact factor: 2.610

3.  Nerve growth factor binding sites on hepatic parenchymal cells.

Authors:  M B Bailie; R A Roth; M L Contreras
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

4.  The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3.

Authors:  C Cordon-Cardo; P Tapley; S Q Jing; V Nanduri; E O'Rourke; F Lamballe; K Kovary; R Klein; K R Jones; L F Reichardt
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

5.  Nerve growth factor: the dark side of the icon.

Authors:  Hubert Hondermarck
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

6.  Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Gregory A Poland
Journal:  Hum Genet       Date:  2012-05-19       Impact factor: 4.132

7.  Stress and reactivation of latent herpes simplex virus: a fusion of behavioral medicine and molecular biology.

Authors:  F J Jenkins; A Baum
Journal:  Ann Behav Med       Date:  1995

8.  Neurotrophin 3 rescues neuronal precursors from apoptosis and promotes neuronal differentiation in the embryonic metanephric kidney.

Authors:  A Karavanov; K Sainio; J Palgi; M Saarma; L Saxen; H Sariola
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  The role of sensory nerve endings in nerve growth factor-induced airway hyperresponsiveness to histamine in guinea-pigs.

Authors:  A de Vries; C van Rijnsoever; F Engels; P A Henricks; F P Nijkamp
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

10.  Topical treatment with nerve growth factor in an animal model of herpetic keratitis.

Authors:  Alessandro Lambiase; Marco Coassin; Nicola Costa; Paolo Lauretti; Alessandra Micera; Emiliano Ghinelli; Luigi Aloe; Paolo Rama; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.